We are a fast-follower, quickly penetrating market with M&A and direct sales force. Nick Deeter, our CEO, was also the founder of Orthopediatrics (NASDAQ:KIDS), the only real competitor in our $2.5 billion addressable market. KIDS has captured 2.3% of the market, leaving the playing field wide open. That's why insiders speak of pediatrics as the last frontier niche. Nick is considered by many as the "pioneer of pediatric orthopedics".